FDA Clearance Tracker · DEN170064
Comaneci, Comaneci Petit, Comaneci 17
Last checked: Nov 20, 2026Latest source record: Apr 24, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Apr 24, 2019
De Novo granted
Time to decision
573 days
Received Sep 28, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN170064
- Device name
- Comaneci, Comaneci Petit, Comaneci 17
- Applicant
- Rapid-Medical , Ltd.
- Applicant location
- Yokneam, IL
- Received
- Sep 28, 2017
- Decided
- Apr 24, 2019
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5955
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN170064
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Rapid-Medical , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Hyperdrive 35 GuidewireThird-party review510(k)
K253146 · Decided Sep 18, 2026 · 358 days after receipt
Device type: Wire, Guide, Catheter (DQX) · Cardiology
K260617 · Decided Aug 28, 2026 · 184 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
- Drivewire 35 Guidewire510(k)
K254006 · Decided Jul 17, 2026 · 214 days after receipt
Device type: Guide, Wire, Catheter, Neurovasculature (MOF) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.